» Pharma Packaging
There is no doubt about the fact that pharmaceuticals packaging or pharma packaging occupies a very important place in the packaging industry. A recent report has shown that the demand for worldwide drug packaging has shown a growth of 5.3 per cent annually and has
reached $24.3 billion (20 7 billion) in 2009. In future the adoption of stricter
regulations and standards governing the production, storage, distribution
and labellings of pharmaceuticals will boost global growth opportunities for
packaging products and accessories.
The European Medicines Agency (EMEA) decision to update guidelines on the
use of plastic packaging in pharmaceuticals is one example of efforts to
improve standards within the industry. The EMEA chose to update its 1994
guidelines on the use of plastic primary packaging materials in light of the
Common Technical Document, which came into force on 1 July 2003.
Types of Pharma Packaging
Send online enquiry for pharma packaging supplies, pharma packaging products, pharma packaging materials, blister packaging, anti counter counterfeit packaging etc. Get the best response from genuine packaging manufacturers and suppliers. Click here to send your enquiry
Pharmaceutical Packaging Regulations
Regulations to govern pharmaceutical packaging not only focus on preserving
the quality of enclosed medication but the emerging threat of product
tampering and counterfeiting means policy must now take a international
perspective. These requirements are now being extended additionally to cover
such criteria the assurance of product dispensing accuracy and the promotion
of patient compliance with product dosage schedules.
Segment-wise, packaging of solid oral ethical and over-the-counter drugs
show sustained growth as they are distributed in large quantities to
institutional and retail pharmacies. Along with this, pharmaceutical pouches
and strip packs generate average growth, while medication tubes provide much
softer growth potential. In the area of parenteral packaging, pre-fillable
syringes fare the best in the marketplace due to advantages in infection
prevention and in emergency response times.
Pharma Packaging Market
US is the largest consumer of pharmaceutical packaging. It is likely to
remain so as the country's advanced proprietary drug producing sector
introduces new sophisticated preparations with specialized storage
requirements. China is expected to register the fastest growth in demand
based on rapidly expanding pharmaceutical manufacturing capabilities and the
phasing-in of a government-mandated program to upgrade the quality of
nationally produced medicines.
Currently, pre-fillable inhalers show great promise over other primary
containers as new asthma and allergy medicines with specialized
administration requirements reach the market. The market for glass
pharmaceutical bottles and jars witness a downturn as applications are lost
to blister packs and high barrier plastic bottles, studies suggest.
Pharmaceutical packaging occupies around 10 to 15 per cent of the overall
drugs and pharmaceutical market and is growing steadily with the same pace
of the industry. Of this, blister packaging has the lead with a 60 per cent
share of the primary packaging market. Primary packaging comes to around 60
per cent of the total packaging industry.
Also, the upbeat trend in the pharma industry also has opened up
considerable opportunities to the packaging machinery development both on
the packaging line operations and end of line operations. Packaging is
already considered an essential aspect of the product in the regulated
markets. Though they are yet to form stringent regulations, the developed
world is now seriously getting aware of the fact that packaging is an